Michael Sprintz
Addiction Medicine · Houston, TXNPI 1013134196
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Abbott at 33.4% of the total. Reporting peaked in 2021 at $647 and has fallen 82.3% since, to $115 in 2025.
Across 76 payments — averaging $30.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$767
- Medtronic$203
- Collegium Pharmaceutical, Inc.$157
- AbbVie$121
- Novo Nordisk$117
- MML US, Inc.$115
- plus $819 from 21 others
Across 34 payments — averaging $1952.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Saluda Medical Americas, Inc.$66K
What the payments were for
- Food & beverage$2,298100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 17 | $767 |
| Medtronic(2 entities) | 3 | $203 |
| Collegium Pharmaceutical, Inc. | 4 | $157 |
| AbbVie | 5 | $121 |
| Novo Nordisk | 1 | $117 |
| MML US, Inc. | 1 | $115 |
| Arbor Pharmaceuticals, Inc. | 6 | $99 |
| Boston Scientific | 3 | $80 |
| Indivior Inc. | 3 | $73 |
| Tersera Therapeutics LLC | 3 | $57 |
| Scilex Pharmaceuticals Inc. | 4 | $56 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $55 |
| Biotissue Holdings Inc. | 2 | $49 |
| Nevro Corp. | 2 | $45 |
| Merz North America, Inc. | 2 | $37 |
| Pacira Therapeutics, Inc. | 2 | $35 |
| Saluda Medical Americas, Inc. | 1 | $29 |
| Almatica Pharma LLC | 2 | $27 |
| Merz Pharmaceuticals, LLC | 1 | $26 |
| Orexo US, Inc. | 2 | $26 |
| Biodelivery Sciences International, Inc. | 2 | $25 |
| Amgen | 1 | $25 |
| Elutia, Inc. | 1 | $18 |
| GRT US Holding, Inc. | 1 | $15 |
| Pfizer | 1 | $15 |
| IBSA Pharma Inc. | 1 | $15 |
| Painteq LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axium INS DRG IPG$168
- VECTRIS$150
- Proclaim IPG$138
- Proclaim Family of SCS IPGs$129
- Ozempic$117
- ReActiv8$115
- Axium$111
- XTAMPZA$103
How this compares
$2,298 in reported general payments places this provider in the 75th percentile of 42 addiction medicine providers in Texas.
Other addiction medicine in Houston
- Thomas KostenHouston$85K
- Gloria MaguadogHouston$14K
- James LaiHouston$6K
- Robert LeathHouston$1K
- Hiroko FuroHouston$620
- Michael WeaverHouston$493
- John MohneyHouston$298
- Kamal ShahHouston$199
- Jason PowersHouston$23
- Jose LeyvaHouston$14
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.